Tykerb (Lapatinib)

Tykerb (Lapatinib) is an antineoplastic drug that contains the active substance lapatinib. It is a selective agent that destroys intracellular tyrosine, a specific protein kinase that binds to specific receptors. Saturation of lapatinib in the blood can be detected approximately four hours after the first dose. The actions of lapatinib will be effective not only when taken as an independent drug, but also when used in combination by patients with metastases in the mammary glands. For women who have a medical condition such as advanced breast cancer, capecitabine is usually given to lapatinib. This combination prevents exacerbation of the disease and significantly reduces the risk of cancer. Tyverb prescription and cancer treatment should be carried out by a qualified specialist, who already has experience in anticancer therapies. Since when treating a malignant tumor, a doctor’s control must be carried out. Before starting treatment, you need to pass testing to assess the mutational status of the HER2 gene. Next, you should determine the percentage of blood volume that is ejected by the left ventricle of the heart, such a procedure should be carried out during treatment to prevent falling below the limit of standard norms.